Sabela Bobillo Selected Research

Sabela Bobillo Research Topics

7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 12/2017
6	Neoplasms (Cancer) 11/2023 - 08/2020
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2018
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 01/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2022 - 12/2013
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2022 - 01/2021
2	acquired Thrombotic thrombocytopenic purpura 11/2022 - 01/2022
2	Lymphoma (Lymphomas) 01/2021 - 01/2021
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 12/2020
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2022
1	Pathologic Complete Response 11/2022
1	Disease Progression 05/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Genetic Translocation (Chromosomal Translocation) 01/2020
1	Hypothyroidism 08/2018
1	Philadelphia Chromosome 05/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2015

5	Chimeric Antigen ReceptorsIBA 01/2024 - 09/2021
3	axicabtagene ciloleucelIBA 01/2024 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2017
3	Rituximab (Mabthera)FDA Link 11/2022 - 12/2013
2	caplacizumabIBA 11/2022 - 01/2022
2	selinexorIBA 08/2020 - 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 05/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	cyclopropapyrroloindoleIBA 01/2021
1	LigandsIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 12/2020
1	ibrutinibIBA 08/2020
1	Antinuclear AntibodiesIBA 08/2018
1	bosutinibIBA 05/2015
1	Tyrosine Kinase InhibitorsIBA 05/2015
1	fludarabineIBA 12/2013
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013